|
Session 132
Poster Abstracts
ART Safety during Pregnancy and Post Partum
Tuesday, 1 - 4 pm
Poster Hall |
745
 |
Pregnancy Outcomes of Women Receiving Efavirenz after the First Trimester
N Phanuphak1, Tanakorn Apornpong*1, S Limpongsanurak2, W Luesomboon3, A Tangsathapornpong4, N Singhakovinta5, C Viravasiri6, P Toro7, E Abrams7, and P Phanuphak1
1Thai Red Cross AIDS Res Ctr, Bangkok; 2King Chulalongkorn Memorial Hosp, Bangkok, Thailand; 3Queen Sawangwattana Memorial Hosp, Chonburi, Thailand; 4Thammasat Univ Hosp, Bangkok, Thailand; 5Queen Sirikit Hosp, Chonburi, Thailand; 6Police Gen Hosp, Bangkok, Thailand; and 7Columbia Univ Mailman Sch of Publ Hlth, New York, NY, US |
| 746 |
Pregnancy and Pregnancy Outcome among Women in the DART Trial
Letitia Namale*1, E Zalwngo2, E Chidziva3, H Wilkes4, R Nalumenya5, C Gilks6, S Mutsai3, C Kityo1, P Munderi2, D Gibb4, and DART Trial Team
1Joint Clin Res Ctr, Kampala, Uganda; 2Med Res Council/Uganda Virus Res Inst, Entebbe; 3Univ of Zimbabwe, Harare; 4Med Res Council Clin Trials Unit, London, UK; 5Academic Alliance, Kampala, Uganda; and 6Imperial Coll, London, UK |
747
|
Safety and Efficacy of Maternal HAART in the Prevention of Early and Late Postnatal HIV-1 Transmission in Mozambique
Leonardo Palombi*1, P Germano2, G Liotta1, M Magnano san Lio2, G Guidotti3, A Assane4, P Narciso5, S Ceffa1, K Nielsen-Saines6, and M Marazzi7
1Univ of Tor Vergata, Rome, Italy; 2DREAM Prgm, Community of S Egidio, Rome, Italy; 3Natl Inst of Hlth, Rome, Italy; 4Ministry of Hlth, Mozambique; 5Natl Inst of Infectious Diseases, L Spallanzani, Rome, Italy; 6David Geffen Sch of Med, Univ of California, Los Angeles, US; and 7LUMSA Univ, Rome, Italy |
| 748 |
Prevalence of Anemia among Women in a Trial of HAART including Zidovudine for PMTCT in Kisumu, Kenya
Timothy Thomas*1, R Masaba1, R Ndivo1, P Nasokho1, C Zeh1, M Thigpen2, M Fowler3, K DeCock4, and L Slutsker2
1Kenya Med Res Inst/CDC, Kisumu; 2CDC, Atlanta, GA, US; 3Makerere Univ-Johns Hopkins Univ Res Collaboration, Kampala, Uganda; and 4WHO, Geneva, Switzerland |
| 749 |
Effect of ART Regimens on Selected Hematologic and Hepatic Parameters of HIV-1-uninfected African Infants
Taha Taha*1, G Kafulafula2, Q Li1, D Hoover3, M Thigpen4, N Kumwenda1, L Mipando2, M Fowler5, and L Mofenson6
1Johns Hopkins Univ Bloomberg Sch of Publ Hlth, Baltimore, MD, US; 2Johns Hopkins Univ Coll of Med Res Project, Blatyre, Malawi; 3Rutgers Univ, Piscataway, NJ, US; 4Natl Ctr for HIV, Viral Hepatitis, STD, and TB Prevention, CDC, Atlanta, GA, US; 5Makerere Univ-Johns Hopkins Univ Res Collaboration, Kampala, Uganda; and 6Natl Inst of Child Hlth and Human Devt, NIH, Rockville, MD, US |
750
|
Atazanavir Use in Pregnancy: A Report of 33 Cases
Macky Natha*1, P Hay1, G Taylor2, G Brook3, L Sarner4, L Cunningham5, J Watson6, C Wood7, J Anderson8, A de Ruiter9, and Perinatal Pregnancy Group, London, UK
1St George's Hosp, London, UK; 2St Mary's Hosp, London, UK; 3Central Middlesex Hosp, London, UK; 4Barts and the London NHS Trust, UK; 5Newham Univ Hosp London, UK; 6Mayday Univ Hosp, London, UK; 7North Middlesex Univ Hosp, London, UK; 8Homerton Univ Hosp London, UK; and 9St Thomas' Hosp, London, UK |
751
|
Treatment Interruption after Pregnancy and Disease Progression: A Report from the Women and Infants Transmission Study
D Watts1, Lynne Mofenson*1, M Lu2, B Thompson2, and for the Women and Infants Transmission Study
1Natl Inst of Child Hlth and Human Devt, NIH, Bethesda, MD, US and 2Clinical Trials & Surveys Corp, Baltimore, MD, US |
752
|
Toxicities from Nevirapine-based ART Regimens in Pregnant Women with CD4 Count between 250 and 350 Cells/mm3
N Phanuphak1, T Apornpong1, S Limpongsanurak2, W Luesomboon3, A Tangsathapornpong4, N Singhakovinta5, C Viravasiri6, P Toro7, E Abrams7, and Praphan Phanuphak*7
1Thai Red Cross AIDS Res Ctr, Bangkok; 2King Chulalongkorn Memorial Hosp, Bangkok, Thailand; 3Queen Sawangwattana Memorial Hosp, Chonburi, Thailand; 4Thammasat Univ Hosp, Bangkok, Thailand; 5Queen Sirikit Hosp, Chonburi, Thailand; 6Police Gen Hosp, Bangkok, Thailand; and 7Columbia Univ Mailman Sch of Publ Hlth, New York, NY, US |
753
|
Maternal Hepatotoxicity with Boosted Saquinivir as Part of Combination ART in Pregnancy
Michelle Hanlon*, S O'Dea, S Clarke, and F Mulcahy
St James's Hosp, Dublin, Ireland |
|
